Thought Leadership
Opinion: Purple Book Patent Listings Are Only a First Step
May 8, 2021
Ted Mathias, Stacie Ropka, and Aaron Savit
The Center for Biosimilars

Axinn partners Ted Mathias and Stacie Ropka, and associate Aaron Savit authored The Center for Biosimilars article, "Opinion: Purple Book Patent Listings Are Only a First Step."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.